Franzè E - Search Results

1

Rafoxanide sensitizes colorectal cancer cells to TRAIL-mediated apoptosis.

Laudisi F, Pacifico T, Maresca C, Luiz-Ferreira A, Antonelli S, Ortenzi A, Colantoni A, Di Grazia A, Franzè E, Colella M, Di Fusco D, Sica GS, Monteleone I, Monteleone G, Stolfi C. Laudisi F, et al. Among authors: franze e. Biomed Pharmacother. 2022 Nov;155:113794. doi: 10.1016/j.biopha.2022.113794. Epub 2022 Oct 4. Biomed Pharmacother. 2022. PMID: 36271571 Free article.

2

Molecular basis of the potential of mesalazine to prevent colorectal cancer.

Stolfi C, Pellegrini R, Franze E, Pallone F, Monteleone G. Stolfi C, et al. Among authors: franze e. World J Gastroenterol. 2008 Jul 28;14(28):4434-9. doi: 10.3748/wjg.14.4434. World J Gastroenterol. 2008. PMID: 18680220 Free PMC article. Review.

3

Involvement of interleukin-15 and interleukin-21, two gamma-chain-related cytokines, in celiac disease.

De Nitto D, Monteleone I, Franzè E, Pallone F, Monteleone G. De Nitto D, et al. Among authors: franze e. World J Gastroenterol. 2009 Oct 7;15(37):4609-14. doi: 10.3748/wjg.15.4609. World J Gastroenterol. 2009. PMID: 19787822 Free PMC article. Review.

4

Characterization of IL-17A-producing cells in celiac disease mucosa.

Monteleone I, Sarra M, Del Vecchio Blanco G, Paoluzi OA, Franzè E, Fina D, Fabrizi A, MacDonald TT, Pallone F, Monteleone G. Monteleone I, et al. Among authors: franze e. J Immunol. 2010 Feb 15;184(4):2211-8. doi: 10.4049/jimmunol.0901919. Epub 2010 Jan 8. J Immunol. 2010. PMID: 20061410

5

Interleukin-25 fails to activate STAT6 and induce alternatively activated macrophages.

Stolfi C, Caruso R, Franzè E, Sarra M, De Nitto D, Rizzo A, Pallone F, Monteleone G. Stolfi C, et al. Among authors: franze e. Immunology. 2011 Jan;132(1):66-77. doi: 10.1111/j.1365-2567.2010.03340.x. Epub 2010 Sep 14. Immunology. 2011. PMID: 20840631 Free PMC article.

6

Interleukin-25 production is differently regulated by TNF-α and TGF-β1 in the human gut.

Fina D, Franzè E, Rovedatti L, Corazza GR, Biancone L, Sileri PP, Sica G, MacDonald TT, Pallone F, Di Sabatino A, Monteleone G. Fina D, et al. Among authors: franze e. Mucosal Immunol. 2011 Mar;4(2):239-44. doi: 10.1038/mi.2010.68. Epub 2010 Oct 13. Mucosal Immunol. 2011. PMID: 20944558 Free article.

7

Targeting interleukin-21 in inflammatory diseases.

Sarra M, Franzè E, Pallone F, Monteleone G. Sarra M, et al. Among authors: franze e. Expert Opin Ther Targets. 2011 Jun;15(6):695-702. doi: 10.1517/14728222.2011.561319. Epub 2011 Mar 11. Expert Opin Ther Targets. 2011. PMID: 21391901 Review.

8

Interleukin-25 negatively controls pathogenic responses in the gut.

Franzè E, Rizzo A, Caruso R, Pallone F, Monteleone G. Franzè E, et al. Inflamm Allergy Drug Targets. 2011 Jun;10(3):187-91. doi: 10.2174/187152811795564028. Inflamm Allergy Drug Targets. 2011. PMID: 21428908 Review.

9

Inhibition of colitis by IL-25 associates with induction of alternatively activated macrophages.

Rizzo A, Monteleone I, Fina D, Stolfi C, Caruso R, Fantini MC, Franzè E, Schwendener R, Pallone F, Monteleone G. Rizzo A, et al. Among authors: franze e. Inflamm Bowel Dis. 2012 Mar;18(3):449-59. doi: 10.1002/ibd.21799. Epub 2011 Jun 17. Inflamm Bowel Dis. 2012. PMID: 21688353

10

2-methoxy-5-amino-N-hydroxybenzamide sensitizes colon cancer cells to TRAIL-induced apoptosis by regulating death receptor 5 and survivin expression.

Stolfi C, Caruso R, Franzè E, Rizzo A, Rotondi A, Monteleone I, Fantini MC, Pallone F, Monteleone G. Stolfi C, et al. Among authors: franze e. Mol Cancer Ther. 2011 Oct;10(10):1969-81. doi: 10.1158/1535-7163.MCT-11-0316. Epub 2011 Aug 4. Mol Cancer Ther. 2011. PMID: 21817114

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

55 results

Search Page